| Literature DB >> 29527295 |
Sushmita Roy1, Mejbah Uddin Ahmed1, Bhuiyan Mohammad Mahtab Uddin1, Zubair Ahmed Ratan2, Monali Rajawat3, Varshil Mehta4, Sojib Bin Zaman5.
Abstract
Introduction: Infections due to antibiotic resistant bacteria have increased alarmingly in both developed and developing countries. Unrestrained and rapidly spreading bacterial growth has turned the management of wound infections into a serious challenge. This study aimed to determine the prevalence of different bacterial pathogens and their antibiotic susceptibility in various types of wound infections.Entities:
Keywords: antibiotic susceptibility pattern; bacterial pathogen; wound infection
Year: 2017 PMID: 29527295 PMCID: PMC5820593 DOI: 10.12688/f1000research.12887.1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1. Pattern of bacterial growth among total samples (N=105).
In this figure, red, magenta, and green portion indicates the Gram Positive, Gram Negative, No growth, respectively and indicates the percentage of bacterial growth.
Figure 2. Rate of isolation of different bacteria (N=97).
Rate of isolation of different bacteria are mentioned here based on number and their corresponding percentage.
Sensitivity pattern of isolated Gram-positive bacteria (N = 61).
| Antimicrobial agents |
| Streptococcus
|
|---|---|---|
| Amoxicillin (10 µg) | 32 (59.3%) | 4 (57.1%) |
| Penicillin (10 µg) | 30 (55.6%) | 4 (57.1%) |
| Vancomycin (30 µg) | 41 (75.9%) | 6 (85.7%) |
| Azithromycin (15 µg) | 44 (81.5%) | 5 (71.5%) |
| Cephradine (30 µg) | 32 (59.3%) | 4 (57.1%) |
| Tetracycline (30 µg) | 32 (59.3%) | 4 (57.1%) |
| Cloxacillin 5( µg) | 31 (57.4%) | 4 (57.1%) |
| Co-trimoxazole (23.7 µg) | 31 (57.4%) | 3 (42.9%) |
| Gentamicin (10 µg) | 42 (77.8%) | 6 (85.7%) |
| Ciprofloxacin (5 µg) | 32 (59.3%) | 4 (57.1%) |
| Cefixime (5 µg) | 40 (74.1%) | 5 (71.5%) |
| Cefuroxime (30 µg) | 32 (59.3%) | 4 (57.1%) |
| Imipenem (10 µg) | 51 (94.4%) | 6 (85.7%) |
| Ceftriaxone (30 µg) | 46 (85.2%) | 6 (85.7%) |
Sensitivity pattern of isolated Gram-negative bacteria (N = 36).
| Antimicrobial Agents | Escherichia
|
|
| Proteus
|
|---|---|---|---|---|
| Cephradine (30 µg) | 10 (43.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Co-trimoxazole (23.7 µg) | 12 (52.2%) | 1 (33.3%) | 1 (12.5%) | 1 (50.0%) |
| Cefixime (5 µg) | 19 (82.6%) | 1 (33.3%) | 1 (12.5%) | 1 (50.0%) |
| Penicillin (10 µg) | 8 (34.8%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Aztreonam (30 µg) | 17 (73.9%) | 1 (33.3%) | 1 (12.5%) | 2 (50.0%) |
| Cloxacillin (5 µg) | 11 (47.8%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Cefuroxime (30 µg) | 18 (78.3%) | 0 (0.0%) | 0 (0.0%) | 2 (100%) |
| Tetracycline (30 µg) | 14 (60.9%) | 0 (0.0%) | 3 (37.5%) | 1 (50.0%) |
| Imipenem (10 µg) | 21 (91.3%) | 1 (33.3%) | 4 (50.0%) | 2 (100%) |
| Ceftriaxone (30 µg) | 21 (91.3%) | 1 (33.3%) | 5 (62.5%) | 2 (100%) |
| Ciprofloxacin (5 µg) | 5 (21.7%) | 0 (0.0%) | 3 (37.5%) | 1 (50%) |
| Azithromycin (15 µg) | 8 (34.8%) | 2 (66.7%) | 3 (37.5%) | 2 (100%) |
| Amoxicillin (10 µg) | 1 (4.3%) | 1 (33.3%) | 0 (0.0%) | 0 (0.0%) |
| Cefotaxime (30 µg) | 20 (86.9%) | 1 (33.3%) | 0 (0.0%) | 1 (50%) |
| Gentamycin (10 µg) | 19 (82.6%) | 3 (100%) | 4 (50%) | 1 (50.0%) |
| Ceftazidime (30 µg) | 18 (78.3%) | 3 (100%) | 3 (37.5%) | 2 (100%) |
| Nitrofurantoin (300 µg) | 18 (78.3%) | 1 (33.3%) | 1 (12.5%) | 1 (50.0%) |